Histogen (HSTO) Revenue & Revenue Breakdown
Histogen Revenue Highlights
Latest Revenue (Y)
$3.77M
Latest Revenue (Q)
$5.00K
Main Segment (Y)
License
Main Geography (Y)
Product
Histogen Revenue by Period
Histogen Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | $3.77M | 310.12% |
| 2021-12-31 | $919.00K | -55.37% |
| 2020-12-31 | $2.06M | -81.79% |
| 2019-12-31 | $11.30M | -66.34% |
| 2018-12-31 | $33.59M | -5.06% |
| 2017-12-31 | $35.38M | 4327.36% |
| 2016-12-31 | $799.05K | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | - |
Histogen generated $3.77M in revenue during NA 2022, up 310.12% compared to the previous quarter, and up 10.65% compared to the same period a year ago.
Histogen Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $5.00K | - |
| 2023-06-30 | $5.00K | - |
| 2023-03-31 | $5.00K | 25.00% |
| 2022-12-31 | $4.00K | -20.00% |
| 2022-09-30 | $5.00K | - |
| 2022-06-30 | $5.00K | -99.87% |
| 2022-03-31 | $3.75M | 75000.00% |
| 2021-12-31 | $5.00K | -99.15% |
| 2021-09-30 | $591.00K | 11720.00% |
| 2021-06-30 | $5.00K | -98.43% |
| 2021-03-31 | $318.00K | -33.47% |
| 2020-12-31 | $478.00K | -3.43% |
| 2020-09-30 | $495.00K | 358.33% |
| 2020-06-30 | $108.00K | -88.96% |
| 2020-03-31 | $978.00K | -37.35% |
| 2019-12-31 | $1.56M | 397.13% |
| 2019-09-30 | $314.00K | -75.37% |
| 2019-06-30 | $1.27M | -81.85% |
| 2019-03-31 | $7.02M | -5.20% |
| 2018-12-31 | $7.41M | -3.35% |
| 2018-09-30 | $7.67M | -12.63% |
| 2018-06-30 | $8.77M | -9.89% |
| 2018-03-31 | $9.74M | 10.59% |
| 2017-12-31 | $8.80M | -7.96% |
| 2017-09-30 | $9.57M | -4.42% |
| 2017-06-30 | $10.01M | 43.02% |
| 2017-03-31 | $7.00M | 775.80% |
| 2016-12-31 | $799.05K | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | - |
Histogen generated $5.00K in revenue during Q3 2023, up 0.00% compared to the previous quarter, and up 100.00% compared to the same period a year ago.
Histogen Revenue Breakdown
Histogen Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|
| License | $3.77M | $27.00K | $882.00K |
| Grant | - | $113.00K | - |
| Professional Services Revenue | - | - | $300.00K |
| Product | - | $892.00K | - |
Histogen's latest annual revenue breakdown by segment (product or service), as of Dec 22: License (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 23 | Jun 23 | Mar 23 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|
| License | $5.00K | $5.00K | $5.00K | $5.00K | $5.00K | $5.00K | $12.00K | $5.00K | $5.00K | $5.00K |
| Grant | - | - | - | - | - | - | $113.00K | - | - | - |
| Product | - | - | - | - | $586.00K | - | $306.00K | - | - | - |
| Professional Services Revenue | - | - | - | - | - | - | - | - | $100.00K | $100.00K |
Histogen's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: License (100.00%).
Histogen Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 |
|---|---|---|
| Grant | $113.00K | - |
| Professional Services Revenue | - | $300.00K |
| License | $27.00K | $882.00K |
| Product | $892.00K | - |
Histogen's latest annual revenue breakdown by geography, as of Dec 21: Product (86.43%), Grant (10.95%), and License (2.62%).
Histogen Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| YS | LakeShore Biopharma | $687.20M | $164.98M |
| CRIS | Curis | $10.02M | $2.55M |
| TNXP | Tonix Pharmaceuticals | $7.77M | $2.21M |
| HSTO | Histogen | $3.77M | $5.00K |
| SNTI | Senti Biosciences | $2.56M | - |
| BLCM | Bellicum Pharmaceuticals | $1.50M | $1.00M |
| BXRX | Baudax Bio | $1.27M | - |
| PALI | Palisade Bio | $250.00K | - |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| CYTO | Altamira Therapeutics | - | $52.73K |
| CING | Cingulate | - | - |
| ALRN | Aileron Therapeutics | - | - |
| HILS | Tharimmune | - | - |
| ENTX | Entera Bio | - | $57.00K |
| DRUG | Bright Minds Biosciences | - | - |
| TPST | Tempest Therapeutics | - | - |
| ARTL | Artelo Biosciences | - | - |
| NEXI | NexImmune | - | - |
HSTO Revenue FAQ
What is Histogen’s yearly revenue?
Histogen's yearly revenue for 2022 was $3.77M, representing an increase of 310.12% compared to 2021. The company's yearly revenue for 2021 was $919K, representing a decrease of -55.37% compared to 2020. HSTO's yearly revenue for 2020 was $2.06M, representing a decrease of -81.79% compared to 2019.
What is Histogen’s quarterly revenue?
Histogen's quarterly revenue for Q3 2023 was $5K, a 0% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $5K, a 0% increase from the previous quarter (Q1 2023), and a 0% increase year-over-year (Q2 2022). HSTO's quarterly revenue for Q1 2023 was $5K, a 25.00% increase from the previous quarter (Q4 2022), and a -99.87% decrease year-over-year (Q1 2022).
What is Histogen’s revenue growth rate?
Histogen's revenue growth rate for the last 3 years (2020-2022) was 83.05%, and for the last 5 years (2018-2022) was -88.78%.
What are Histogen’s revenue streams?
Histogen's revenue streams in c 22 are License
What is Histogen’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Histogen was License. This segment made a revenue of $3.77M, representing 100.00% of the company's total revenue.